STIFTELSEN UNIVERSITETSFORSKNI has a total of 25 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United Kingdom, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are GOLZ STEFAN, BERG BIOSYSTEMS LLC and BIOCORTECH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Norway | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 2 | |
#7 | United States | 2 | |
#8 | China | 1 | |
#9 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Computer technology | |
#5 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Vedeler Christian Alexander | 7 |
#2 | Nyland Harold Inge | 7 |
#3 | Myhr Kjell-Morten | 6 |
#4 | Gerdes Hans-Hermann | 5 |
#5 | Taxt Torfinn | 3 |
#6 | Rustom Amin | 3 |
#7 | Gruener Renate | 2 |
#8 | Lillehaug Johan R | 2 |
#9 | Hodneland Erlend | 2 |
#10 | Fjellbirkeland Anne | 2 |
Publication | Filing date | Title |
---|---|---|
NO20074772L | Systems for expression of heterologous proteins in M. capsulatus | |
WO2006125674A1 | Microscope system and screening method for drugs, physical therapies and biohazards | |
GB0609610D0 | MR perfusion | |
GB0522986D0 | MR perfusion | |
CN101002104A | Blind determination of the arterial input and tissue residue functions in perfusion mri | |
US7316913B2 | Methods and means for influencing intracellular communication and intracellular organelle transport | |
AU5256700A | Detection of ryanodine receptor antibodies | |
AU1772999A | Method for disease prognosis based on Fc receptor genotyping | |
GB9802208D0 | Method and use | |
GB9802207D0 | Method | |
GB9727056D0 | Method and use | |
GB9727055D0 | Method |